Luminex Corp (LMNX):企業の財務・戦略的SWOT分析

◆英語タイトル:Luminex Corp (LMNX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME1335FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Luminex Corp (LMNX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Luminex Corp (Luminex) develops, manufactures and markets proprietary biological testing technologies. The company offers wide range of products including assays, instruments, reagents and accessories, software and replacement parts. It employs its proprietary technologies to test for proteins and nucleic acids, and to serve multiplexing, precision, sensitivity, accuracy, and for reduction of labor. Luminex offers its products to various markets such as pharmaceutical drug discovery; clinical diagnostics; biomedical research including personalized medicine and genomic research. The company sells its products through direct sales channel and strategic distribution partners in Asia-Pacific North America and Europe. Luminex is headquartered in Texas, the US.

Luminex Corp Key Recent Developments

Feb 08,2021: Luminex Corporation Reports Fourth Quarter and Full-Year 2020 Results
Jan 29,2021: The faces of Luminex: Rico Weterings, customer operations
Jan 12,2021: Luminex pre-release of 4th quarter 2020 revenue
Nov 05,2020: Luminex reports strong third quarter 2020 results
Oct 07,2020: Luminex pre-release of 3rd quarter 2020 revenue

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Luminex Corp – Key Facts
Luminex Corp – Key Employees
Luminex Corp – Key Employee Biographies
Luminex Corp – Major Products and Services
Luminex Corp – History
Luminex Corp – Company Statement
Luminex Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Luminex Corp – Business Description
Business Segment: Assay
Overview
Performance
Business Segment: Consumables
Overview
Performance
Business Segment: Other
Overview
Performance
Business Segment: Royalty
Overview
Performance
Business Segment: Service
Overview
Performance
Key Stats
Business Segment: System
Overview
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Canada
Performance
Geographical Segment: Domestic
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Other Regions
Performance
R&D Overview
Luminex Corp – Corporate Strategy
Luminex Corp – SWOT Analysis
SWOT Analysis – Overview
Luminex Corp – Strengths
Luminex Corp – Weaknesses
Luminex Corp – Opportunities
Luminex Corp – Threats
Luminex Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Luminex Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Luminex Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Luminex Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 08, 2021: Luminex Corporation Reports Fourth Quarter and Full-Year 2020 Results
Jan 29, 2021: The faces of Luminex: Rico Weterings, customer operations
Jan 12, 2021: Luminex pre-release of 4th quarter 2020 revenue
Nov 05, 2020: Luminex reports strong third quarter 2020 results
Oct 07, 2020: Luminex pre-release of 3rd quarter 2020 revenue
Oct 07, 2020: For COVID-19 detection and epidemiology, xMAP technology offers unique advantages
Aug 04, 2020: Luminex announces departure of G. Walter Loewenbaum from its Board of Directors
Aug 04, 2020: Luminex reports second quarter 2020 results
Jul 08, 2020: Luminex pre-release of 2nd quarter 2020 revenue
Jun 29, 2020: Luminex: Results of Operations and Financial Condition
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Luminex Corp, Key Facts
Luminex Corp, Key Employees
Luminex Corp, Key Employee Biographies
Luminex Corp, Major Products and Services
Luminex Corp, History
Luminex Corp, Other Locations
Luminex Corp, Subsidiaries
Luminex Corp, Key Competitors
Luminex Corp, Ratios based on current share price
Luminex Corp, Annual Ratios
Luminex Corp, Annual Ratios (Cont...1)
Luminex Corp, Annual Ratios (Cont...2)
Luminex Corp, Interim Ratios
Luminex Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Luminex Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Luminex Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Luminex Corp (LMNX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AMO Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary AMO Pharma Ltd (Amo Pharma) is a biopharmaceutical company that develops novel treatments for serious and debilitating diseases. The company provides pipeline product portfolio such as AMO-01, and AMO-02. Its AMO-01 is being developed for the treatment of autism and intellectual disabilities …
  • Euro-Diagnostica AB:医療機器:M&Aディール及び事業提携情報
    Summary Euro-Diagnostica AB (Euro Diagnostica) is a medical device company that manufactures and markets purified antigens and antibodies. The company offers blood based solutions, developed to aid clinicians in diagnosis, prognosis, monitoring and treatment of autoimmune diseases. It offers product …
  • Ashland Global Holdings Inc (ASH):企業の財務・戦略的SWOT分析
    Ashland Global Holdings Inc (ASH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Nordea Bank AB:企業の戦略・SWOT・財務情報
    Nordea Bank AB - Strategy, SWOT and Corporate Finance Report Summary Nordea Bank AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Opsona Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Opsona Therapeutics Ltd (Opsona) is a drug developing company that conducts research, develops and commercializes new treatment for the autoimmune and inflammatory diseases and cancers. The company's OPN-305 is a humanized antibody used to reduce pro-inflammatory cytokine production that is …
  • Kungsleden AB:企業のM&A・事業提携・投資動向
    Kungsleden AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kungsleden AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Dow Brasil SA:企業の戦略的SWOT分析
    Dow Brasil SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Energy World Corp Ltd (EWC):電力:M&Aディール及び事業提携情報
    Summary Energy World Corp Ltd (Energy World) is an energy company that produces and sells power and develops liquiefied natural gas projects. The company's activities include design, construction, operation, and maintenance of independent power projects, liquefied natural gas plants, and gas process …
  • HTL International Holdings Limited:企業の戦略的SWOT分析
    HTL International Holdings Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Biotron Ltd (BIT):企業の財務・戦略的SWOT分析
    Biotron Ltd (BIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Patterson-UTI Energy Inc (PTEN):企業の財務・戦略的SWOT分析
    Patterson-UTI Energy Inc (PTEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Vattenfall AB-エネルギー分野:企業M&A・提携分析
    Summary Vattenfall AB (Vattenfall) is a state-owned energy company that generates, distributes and sells electricity and heat. It is one of the leading generators of electricity and heat in Europe. The company also conducts the sale of gas and energy trading. Vattenfall generates power through vario …
  • AnGes Inc (4563):医療機器:M&Aディール及び事業提携情報
    Summary AnGes Inc (AnGes) is a biopharmaceutical company which discovers and develops gene and nucleotide based drugs and reagents for use in functional analysis of genetic medication. The company specializes in research and development (R&D) and practical application of genetic medicine. It has two …
  • Air New Zealand Limited:企業の戦略・SWOT・財務情報
    Air New Zealand Limited - Strategy, SWOT and Corporate Finance Report Summary Air New Zealand Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Rubius Therapeutics Inc (RUBY):製薬・医療:M&Aディール及び事業提携情報
    Summary Rubius Therapeutics Inc (Rubius Therapeutics) is a biotechnology company that focuses on the development of medicines for the treatment of rare diseases, cancer and autoimmune diseases. The company through its rubius erythrocyte design (RED) platform engineer and culture Red Cell Therapeutic …
  • Diffusion Pharmaceuticals Inc (DFFN):企業の財務・戦略的SWOT分析
    Summary Diffusion Pharmaceuticals Inc (Diffusion), formerly Diffusion Pharmaceuticals LLC is a clinical stage biotechnology company that develops standard of care therapies. The company improves cancer treatments such as radiation therapy and chemotherapy in treatment-resistant solid tumors, includi …
  • Seacoast Banking Corporation of Florida:企業の戦略・SWOT・財務情報
    Seacoast Banking Corporation of Florida - Strategy, SWOT and Corporate Finance Report Summary Seacoast Banking Corporation of Florida - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Mars Incorporated:企業の戦略的SWOT分析
    Mars Incorporated - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Biocept Inc (BIOC):医療機器:M&Aディール及び事業提携情報
    Summary Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell l …
  • Coresa SA:企業の戦略・SWOT・財務情報
    Coresa SA - Strategy, SWOT and Corporate Finance Report Summary Coresa SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆